ReportWire

Tag: PillSafe

  • PillSafe Could Save Millions for Medicaid Programs Battling Costs and Prescription Oversight Issues

    [ad_1]

    As the federal government seeks to cut Medicaid expenses, the groundbreaking smart pill bottle technology can help by providing physicians, pharmacists and industry with improved medication adherence and prescription oversight and accountability.


    EDMOND, Okla., March 25, 2025 (Newswire.com)
    –
    The Medicaid program has been identified as source of potential cost savings by the Trump administration. PillSafe, a groundbreaking smart pill bottle technology, provides a critical solution that could save millions for Medicaid by improving prescription oversight, reducing waste, and increasing compliance.

    “With Medicaid programs under increasing pressure to cut costs while maintaining patient care, the need for smarter prescription oversight has never been greater,” said Jim Patton, co-founder of PillSafe. “PillSafe provides a practical, technology-driven solution that enhances compliance, reduces waste, and improves communication between doctors, pharmacists, and patients. By integrating real-time monitoring and secure dispensing, we can help Medicaid programs save millions while ensuring medications are used safely and effectively.”

    Medicaid is a shared federal and state program that provides care for one out of every five Americans, including nearly 40% of children and half of all adults in poverty. It also covers the cost of nearly 41% of births and over 60% of nursing home patients. However, its $880 billion in spending also includes waste from prescription noncompliance and unused medications, which also can result in drug abuse and preventable hospitalizations. As costs continue to rise, PillSafe technology offers a modern and efficient way to address these challenges.

    With its advanced access control and monitoring capabilities, PillSafe ensures that prescriptions are taken as directed and that doctors, pharmacists, and patients remain accountable. The smart pill bottle restricts access to the patient via a serialized dispenser that requires inputting codes unique to the patient and delivery. Safety features also include an electronic pill counter and timed-release system. PillSafe also has a fail-safe security net that can destroy the medication if anyone attempts to circumvent its systems and uses direct wireless notifications that confirm compliance between patients and their healthcare providers.

    By improving communication between patients and doctors, PillSafe prevents unnecessary refills, minimizes medication waste, and supports better health outcomes – ultimately reducing Medicaid’s overall prescription drug costs.

    The Centers for Medicare & Medicaid Services (CMS) set oversight guidelines for Medicaid drug programs, but enforcing these policies and ensuring safe use of medications remains a challenge. A study by the Centers for Disease Control and Prevention determined that Medicaid beneficiaries had almost six times the risk of dying from a prescription drug overdose compared to people not in the program.

    PillSafe’s real-time tracking and secure dispensing technology provide an additional layer of accountability, ensuring that medications reach the right patients at the right time and are taken as prescribed. This level of monitoring supports state and federal efforts to control prescription drug spending while safeguarding patient care.

    “State Medicaid programs are losing millions to prescription oversight issues, from medication waste to fraud to noncompliance,” said Dr. John Barr, inventor and co-founder of PillSafe. “As policymakers look for ways to cut spending without jeopardizing care, technology-driven solutions like PillSafe offer a practical and effective way to enforce compliance, reduce waste, and improve patient outcomes.”

    Beyond cost savings, PillSafe plays a crucial role in reducing prescription drug abuse, a persistent issue affecting Medicaid and healthcare programs nationwide. By limiting access to medication through time-release technology and preventing unauthorized use, PillSafe enhances patient safety while lowering the risk of fraud and diversion.

    As the federal government seeks ways to rein in healthcare spending, PillSafe represents a vital step forward – one that benefits patients, doctors, and Medicaid programs alike. By combining smart technology with real-time oversight, PillSafe offers a scalable and cost-effective solution to one of the most pressing issues in healthcare today.

    For more information about PillSafe and how it can help Medicaid programs reduce costs and improve oversight, visit www.pillsafe.com.

    About PillSafe

    PillSafe is a revolutionary “smart” delivery solution for additive medications that redefines medication management, compliance, safety, and reporting for controlled substances.

    Unlike current medication bottles that leave patients vulnerable, with simple reminders and open access, PillSafe ensures secure, patient only access and dosage control, preventing prescription diversion and abuse. Other technology enhances includes an electronic label for enhanced patient messaging, two-step verification, and targeted advertising, benefiting all stakeholders from manufacturers to patients. For information on licensing the PillSafe patented “Smart” Technologies, contact us at www.pillsafeprotection.com.

    Contact Information

    Source: PillSafe

    Related Media

    [ad_2]

    Source link

  • PillSafe Provides a Solution to the Opioid Epidemic’s $1 Trillion-Plus Impact on the US Economy

    PillSafe Provides a Solution to the Opioid Epidemic’s $1 Trillion-Plus Impact on the US Economy

    [ad_1]

    As federal and state governments implement far-ranging programs to address the crisis, PillSafe offers a technology-based solution that ensures patients comply with prescriptions.


    EDMOND, Okla., May 14, 2024 (Newswire.com)
    –
    The nation’s opioid epidemic costs the U.S. economy more than $1 trillion a year in lost labor hours, productivity, and healthcare costs. The federal and state governments are launching complex and costly programs to address the crisis. Yet, products like the PillSafe bottle, a patented “smart” pill delivery system, offer an efficient, technology-based solution.

    Developed by doctors and designed to protect patients, PillSafe uses proprietary technology that distributes the appropriate amount of medication at the time prescribed by the doctor and prevents tampering with the bottle, ensuring compliance with the doctor’s prescription.

    PillSafe was developed to address an overdose epidemic that has killed more than 100,000 people in the United States every year since 2001 and is the leading killer of people 18 to 49 in the United States. From 2015-2018, the opioid epidemic cost the U.S. economy $2.5 trillion. In 2020 alone, the epidemic imposed a $1.5 trillion burden on the economy, equivalent to 7% of that year’s GDP.

    “Addressing this crisis requires continued efforts and resources to combat addiction and reduce fatal overdoses. Dollars and education alone will not solve the Opioid challenge. Funding ‘smart’ technologies is the next step,” said Dr. John Barr, co-founder of PillSafe.

    A review of recent legislation and programs from the federal government and several state governments, including New York, Illinois, and Washington, illustrates the extraordinary and expensive efforts dedicated to the opioid crisis.

    The U.S. Congress has passed three laws, the Comprehensive Addiction and Recovery Act (CARA), the 21st Century Cures Act, and the SUPPORT for Patients and Communities Act, that will spend more than $10.6 billion by 2028 on programs to decrease the supply and demand for opioids.

    The Department of Health and Human Resources (HHS) mentioned in a March 2020 report that $300 million, almost one-third of the State Targeted Response to the Opioid Crisis grant program’s $970 million funding, was not spent by some of the states. Another 14 states spent less than half of their funding share. All but six states asked for a 12-month extension.

    The federal government’s Department of Labor has a program that hires individuals in recovery, providing fidelity bonds for “at-risk” and difficult-to-place job seekers. The bonds cover the first six months of employment at no cost to the job seeker or the employer. Also, New York and Illinois governments have created tax credits to incentivize employers to hire individuals in recovery. The U.S. Chamber of Commerce also promotes resources for second-chance hiring programs.

    According to a survey by the National Safety Council, 75% of employers reported that opioid use has impacted their workplace, and only 17% reported being extremely well-prepared to address the issue. An estimated 12.6% of the American workforce receives an opioid prescription today. Workers with substance use disorders take 50% more unscheduled leave and have a turnover rate 44% higher than other people. Workers affected by opioids are also more likely to experience occupational injuries that result in time away from work.

    The State Opioid Response grant program has allowed states to provide treatment services to over 1.2 million people in the U.S. since 2018, purchase roughly 10 million overdose reversal medication kits that helped with 550,000 overdoses, and offer funding for access to medications, treatment of opioid use disorder, and increase prevention, harm reduction, treatment, and recovery support services for substance use disorder.  

    State governments across the country have approved or are planning elaborate programs to address the opioid crisis and its impact on the economy. New York and Illinois have created tax credits to incentivize employers to hire individuals in recovery. In Washington, the governor approved a measure in March to help tribes and indigenous people deal with their soaring overdose death rates. It would provide nearly $8 million annually until at least 2031 for the state’s 29 federally recognized tribes.  

    In Texas, where a study showed that overdoses in 2022 cost the state $114.6 billion in gross product and 1.2 million years of work, the state is expected to spend about $700 million from a settlement with pharmaceutical companies on programs to reduce opioid addiction.  

    Given the scope of the issue and governments’ scattershot response, the PillSafe developers want to announce an open invitation to partner with any State on sharing the licensing revenues from PillSafe technologies in support of their incentive programs on Employment, Compliance, and Recovery. We invite State Representatives to contact the PillSafe team at https://pillsafeprotection.com.

    About PillSafe  
    PillSafe is a pioneering “smart” technology that shifts the standard of care in the pharmaceutical industry with home delivery and patient compliance in response to the opioid epidemic. The company creates prescription compliance by restricting access to medication to only the patient, keeping medication safe from divergence and abuse. PillSafe’s “intelligent” design includes several innovative features that benefit the delivery network from the manufacturer to the pharmacy to the patient. The patented technology includes an electronic label that can increase adherence messaging, two-step verification, or active advertising from the manufacturer to the pharmacy to the patient.

    In 2022, 27 million Americans had a drug use disorder. The economic impact of opioids has been substantial, affecting lives, families, and the working population directly. A CDC review of mortality data from 21 states reported that unintentional overdose deaths accounted for a disproportionate share of all deaths in six occupational groups: construction, extraction (e.g., mining), food preparation and serving, health care practitioners, health care support, and personal care and service.

    Source: PillSafe

    [ad_2]

    Source link